In a setback to states fighting the opioid epidemic, a federal judge ruled a New York state law that would have required opioid makers and distributors to fund a first-in-the-nation program for covering costs for treatment, prevention, and recovery is unconstitutional.

Under the Opioid Stewardship Act, which was enacted last July, opioid makers and wholesalers were expected to pay an estimated $600 million in surcharges over the next six years. The law marked the first time a state government sought to tax these companies as a way to fight the opioid crisis.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy